drugset / Trial / NCT04765553
A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.
RandomizedParallel-groupSingle-blindOther
Summary
This is a randomized, placebo controlled and double-blinded study to evaluate the pharmacokinetics (PK), pharmacodynamics (PD) and safety of a single dose (1 mg/kg) of emapalumab in adult healthy Japanese subjects.
Timeline
- Start
- 2021-01-14
- Primary completion
- 2021-06-25
- Completion
- 2021-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Emapalumab | Monoclonal antibody | 1 mg/kg | Intravenous |
Indications
No indication recorded.